Stocks · Health care · Biological Products, (No Diagnostic Substances)

Replimune Group, Inc.

REPL Clue Score21
United States Fiscal year ends March CIK 0001737953 Results filed 28 Oct 2026

What the insiders did Net selling

Nothing of that kind in this period.

What was left out

Form 4 filings counted 282
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 25
Sales on a Rule 10b5-1 plan 9
Sales straight out of an exercise 32
Sales at will 226
Transactions with no price 0
Shares from compensation/vesting 31,126,773
Sales filed before the plan box existed 186
History held since 25 Jul 2018